ABVC BioPharma, Inc. Shares Issued, Value, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. shares issued, value, share-based payment arrangement, forfeited for the quarter ending 2025-12-31 was $739.99K.
- ABVC BioPharma, Inc. shares issued, value, share-based payment arrangement, forfeited for the quarter ending 2025-09-30 was $1.31M.
- ABVC BioPharma, Inc. shares issued, value, share-based payment arrangement, forfeited for fiscal 2025 was $2.50M.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Value, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2025-12-31 | $739.99K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-03 | $2.50M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.31M 10-Q/A · filed 2026-03-03 |